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a b s t r a c t
Introduction: Open vascular surgery and endovascular (EV) interventions are continually
developing and their application differs depending on the arterial regions treated. We aim to
demonstrate that current EV procedures do not mean a restriction, but on the contrary, an
increase in the number of patients who can be successfully treated.
Methods: We have retrospectively followed all open surgery procedures and endovascular
interventions done for carotid artery stenosis and subrenal abdominal aortic aneurysms
(AAA) from 1990/1993 to 2014 in the Vascular Surgery Department at Na Homolce Hospital.
Results: From 1990 to 2014, 1659 open AAA surgery procedures were done in our department.
Since 1996, 1023 endovascular abdominal aortic aneurysm repairs (EVAR) have been per-
formed and since the implementation of robotics, 64 aneurysm replacements were robot-
assisted. Mortality rates in the OS, EVAR and robotic groups are 1.7%, 1.5% and 0.4%,
respectively. The percentage of EVAR stabilized during the last 5 years at about 32% of
the total number of treated patients. From 1993 to 2014 there were 5363 open carotid surgery
procedures done in our department, 2856 for symptomatic and 2507 for asymptomatic
stenosis. The total cohort combined stroke/death rate was 1.6%. Symptomatic, asymptom-
atic and urgently operated patients had a combined 30-day stroke/death rate of 1.0%, 1.7%
and 4.4%, respectively. During the same period 274 carotid bifurcation and 55 common
carotid artery percutaneous transluminal angioplasty (PTA) were done. The technical
success of endovascular interventions was better than 95%.
Conclusion: In the AAA group, the percentage of EVAR stabilized during the last 5 years at
about 32% of the total number of treated patients. Given the excellent results of open carotid
surgery and the unconvincing results of stenting trials, we consider open carotid surgery to
be better than carotid artery primary stenting.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights
reserved.
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The history of open vascular surgery is relatively long in
comparison with endovascular interventions. Vascular suture
was ﬁrst used in the 16th century and vascular anastomosis
suture was developed during the second half of the
20th century, but the greatest increase in vascular surgery
procedures came after 1955 with the commercial production
of artiﬁcial vascular prostheses (Dubost, Cooley and
DeBakey) [1].
The history of endovascular interventions is much shorter
but also more rapid. Atraumatic percutaneous access was
ﬁrst described in 1953 (Seldinger) and angioplasty with a
conical catheter and later with the angioplasty balloon were
ﬁrst performed in the sixties [2]. Angioplasty was quickly
combined with metallic stents. Volodos (1986) and Parodi
(1990) improved the procedure of endovascular aneurysm
therapy using covered stents, termed stent grafts (SG). Each of
these methods, i.e. angioplasty, stenting and stent grafting
have undergone rapid and continuous development, and their
application differs depending on the arterial regions.
The increased numbers of endovascular (EV) procedures
are often a reﬂection of the hope shown by physicians and
patients. Nevertheless, modern methods do not generally
demonstrate better clinical results, at least not in all situa-
tions, and under certain conditions EV procedures are not seen
as a viable life-long solution.
On the evidence from a single center and using the example
of two types of vascular impairments we will demonstrate that
current EV procedures do not mean a restriction, but on the
contrary an increase, in the number of patients who can be
successfully treated.
Methods
We have retrospectively followed all open surgery (OS) and EV
interventions done for carotid artery stenosis and subrenal
abdominal aortic aneurysms (AAA) from 1990/1993 to 2014 in
the Vascular Surgery Department at Na Homolce Hospital.
These two vascular impairments were chosen because they
represent a signiﬁcant number of open vascular and endo-
vascular surgery procedures. A number of studies comparing
the OS and EV approaches to the abdominal aorta and carotid
bifurcation have been published during recent years.
Abdominal aortic aneurysm
In general, patients indicated to treatment are either asymp-
tomatic with AAA transverse diameter ≥55 mm, symptomatic
with any aneurysm diameter or those with a rapid increase of
aneurysm diameter over 5 mm per year [3].
Open AAA surgery has been successfully performed since
the sixties and in many centers it is the treatment method of
1st choice. Vascular prostheses have not substantially chan-
ged during the last 30 years. Open surgical procedures and
their results are historically proven and well documented [4].
A 25-year history of endovascular aneurysm repair with
stent graft (EVAR) has brought improvement in core stenttechnology, prosthetic covering material, introducer sheaths
and, in the last generation, a portfolio of fenestrated and
branched components. According to manufacturers' instruc-
tions for use, the required length for sealing in the proximal
neck ranges from 15 to 20 mm, but sometimes stent grafts are
used even in shorter necks of 7.5 to 10 mm in length.
Fenestrated off-the-shelf stent grafts, available in recent
years, enable the treatment of juxtarenal aneurysms and
aneurysms of the visceral segment without the signiﬁcant
delay caused by customized manufacturing. In our center, the
majority of SG implantations are done in selected asymptom-
atic or symptomatic patients with moderate or high risk (GAS
score >90 or NYHA class III–IV).
Endovascular sealing (EVAS) is a new concept in the
treatment of aortic aneurysms [5]. The system consists of
two PTFE-covered stent grafts of standard 10 mm diameter
surrounded with large bags. They are inserted into the
aneurysm. After appropriate SG positioning, both the endo-
bags are ﬁlled with biostable polymer, sealing completely the
aneurysm sack, the origins of the inferior mesenteric artery, all
the lumbar arteries and also the proximal neck in the subrenal
portion and distal ends in both common iliac arteries. We
treated two patients with this system in 2014 (Fig. 1a and b).
Endovascular sealing is indicated for patients with irregular
and conical necks unsuitable for standard SG. Another
advantage of aneurysm sack sealing is the prevention of all
types of endoleak.
Since 2006 we have been able to select anatomically
suitable patients for robot-assisted laparoscopic surgery.
The introduction of robotics marked a fundamental turning
point for laparoscopic vascular surgery, which had always
entailed relatively difﬁcult manipulation with instruments
and required a long time to construct the vascular anastomo-
sis, leading to long aortal clamping times. The robotic system
removes these fundamental disadvantages of laparoscopy and
opens up the possibility of expanding robot-assisted laparo-
scopic surgery in this area.
Robotic technology has been applied in a range of vascular
reconstructions of the pelvic arteries, visceral arteries and
abdominal aorta. This has ranked the hospital alongside a
small number of centers worldwide – able to be counted on
the ﬁngers of one hand – where robotic-assisted vascular
reconstructions are routinely performed. The experience in
the ﬁeld of vascular surgery allows us to claim that vascular
anastomosis can be performed robotically both on the aorta
and the pelvic artery with good results and, in fact, more easily
than with classical laparoscopic surgery. Robotic vascular
procedures can be categorized by surgical site into interven-
tions in the pelvic region, aortic interventions, visceral arteries
interventions, thoracic aortic interventions and hybrid proce-
dures.
Compared with open surgery, the robotic system results in
a shortened ICU stay, decreased post-surgery pain and
accelerated rehabilitation.
Results
Our center gradually introduced all types of AAA treatment.
The proportion and number of interventions over consecutive
years are depicted in Fig. 2. From 1990 to 2014, 1659 open AAA
Fig. 1 – CT angiography after application of EVAS, Nellix
system (Endologix, CA, USA). Polymer filled endobags
follow the inner contours of the aneurysm sack.
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introduction of the endovascular program in 1996, 1023
EVAR have been performed. During the ten years since the
implementation of robotics, 64 aneurysm replacements
were robot assisted. In that period, mortality rates in the
OS, EVAR and robotic groups are 1.7%, 1.5% and 0.4%
respectively.
The introduction of endovascular and robotic assisted
procedures has not caused a decrease in the volume of OS
procedures, but, on the contrary, has increased chancesof treating those patients for whom the risk with the
classical procedure is high. The endovascular approach is
also advantageous for patients in the reoperation group. It is
possible to avoid repeated laparotomy and the SG can be
anchored in the already present vascular prosthesis.
The percentage of EVAR stabilized during the last ﬁve years
at about 32% of the total number of treated patients. Over the
years, the use of various SG types has also varied due to
technical improvements and physician experience (Fig. 3).
Originally only tubular stent grafts were on the market, but
only a few patients were anatomically suitable for tubular SG
in the abdominal position, and very often, distal endoleak
type I occurred.
Carotid artery bifurcation stenosis
Open endarterectomy of carotid artery (CA) bifurcation was
performed for the ﬁrst time more than 60 years ago. The
indication criteria have changed during the last ten years:
symptomatic stenosis 350% should be treated as soon as
possible after the ﬁrst transitory ischemic attack (TIA) or
stroke, provided that the ischemic lesion is smaller than 1/3 of
the area supplied by a. cerebri media. The ideal timing for
procedure is up to 48 h, and no longer than 14 days after the
ﬁrst embolization episode. In asymptomatic lesions 370%,
best medical therapy (BMT) is recommended initially, and
intervention should be offered to patients with frequent
microemboli on trans-cranial Doppler, with echolucent and
progressing plaques [6–8].
Open endarterectomy should be performed at specialized
vascular centers with a combined number of stroke/periop-
erative death of <2% [9]. The rate of restenosis is about 4% [10].
The average ICU stay is 6 h and the length of hospital stay
(LOS) is typically about 4 days. A large number of open
procedures (>25/year) done by a single surgeon is the most
important factor for sustained and durable results. The
speciﬁc surgery technique (eversion versus longitudinal
incision) does not signiﬁcantly inﬂuence the long-term
results, but generous usage of patch plasty decreases the
amount of restenosis and combined perioperative and long-
term stroke risk [10,11]. Specialized centers have an average
stroke/death rate of 1.5–2% in cohorts of both symptomatic
and asymptomatic patients [12]. Thus, open carotid endarter-
ectomy remains standard care for patients with carotid artery
stenosis [13].
In a signiﬁcant number of patients it is not possible to
perform an open procedure due to various objective or
subjective reasons. The most frequent indications for EV
procedure are listed in Table 1. The general criteria for EV
procedure are the same as for OS. However, EV procedure also
has its contraindications: fresh adhering thrombus, ﬁliform
(>95%) or long (>2 cm) stenosis, severe artery tortuosity/
kinking, neighboring aneurysmal dilatation or severe allergic
reaction to contrast media. The ICU stay is also about 6 h on
average and the length of stay is typically about 24 h.
The most serious complication of the EV approach is
embolic stroke. The number of severe strokes is signiﬁcantly
reduced with the use of protection tools, but the incidence of
subclinical microembolizations is probably higher. Carotid
endarterectomy versus carotid stenting randomized trials
Fig. 2 – Proportion of interventional methods over consecutive years.
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many strokes and deaths and more periprocedural deaths or
myocardial infarctions or strokes compared with surgery,
partly due to inadequate experience among endovascular
teams and the non-compulsory use of protective instruments
[14–18]. Despite that, many vascular societies in the recent
intervention guidelines have adopted new positive recom-
mendations for carotid artery stenting (CAS) for both asymp-
tomatic and symptomatic stenosis. In-stent restenosis and
stent thrombosis are late complications with a rate from 3 to
6% after 3 years [19].Fig. 3 – Evolution of stent graft types anResults
In our center, patients are normally offered open endarterec-
tomy. Endovascular procedures are therefore indicated only
under the conditions listed in Table 1. Thus, open surgery and
EV cohorts are not comparable.
From 1993 to 2014 there were 5363 open carotid surgery
procedures done in our department, 2856 for symptomatic and
2507 for asymptomatic stenoses. The total cohort combined
stroke/death rate was 1.6%. Symptomatic, asymptomaticd their use over consecutive years.
Table 1 – Indication for endovascular treatment for carotid
artery bifurcation stenosis.
Indication
1 Early post-endarterectomy restenosis (up to 24 months,
method of the ﬁrst choice)
2 Persons with high risk of perioperative acute myocardial
infarction, or persons with indication for contemporary
coronary and carotid EV procedure
3 Persons with a history of congestive heart failure
4 Hostile terrain, large scarring, a history of irradiation or
regional ENT surgery
5 Non-accessible lesions close to cranial base or low on the
common carotid artery, below the clavicle
6 A lesion of the contralateral n. laryngeus recurrens,
n. pharyngicus
7 Severe chronic respiratory or renal failure
8 Patient preference
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death rate of 1.0%, 1.7% and 4.4%, respectively. Cervical nerve
lesions occurred in 11% of cases. Post-operative hemorrhage
was recorded in 1.1% of procedures. During the same period
274 carotid bifurcation and 55 common carotid artery
percutaneous transluminal angioplasty (PTA) were done.
While PTA was seldom indicated as a ﬁrst procedure for
carotid stenosis, in the great majority of cases patients with
restenosis after primary surgery were indicated for PTA.
Technical success was better than 95%. The proportion and
number of interventions over consecutive years are depicted
in Fig. 4. Given the excellent results of open surgery and the
unconvincing results of stenting trials, we consider open
carotid surgery to be better than carotid artery primary
stenting.
Discussion
We have selected carotid and AAA interventions, two major
topics in the ﬁeld of vascular surgery, as the subject of our
study, as they represent a signiﬁcant proportion of the
procedures performed in the Vascular Surgery DepartmentFig. 4 – Contribution of carotid stenosis treatment methods. Propo
Impact of the new guidelines caused a decrease in the number 
decrease in the total number of open procedures.at Na Homolce Hospital. We aim to document that the
movement toward more EV interventions is not straightfor-
ward as often they do not provide a complete solution.
Physicians have to manage not only technical and anatomical
problems, but also important ethical, logistical and personal
issues, leaving aside the question of health ﬁnance.
For AAA, the original and still valid indication for EVAR is
the elective treatment of patients for whom surgery is very
risky. In a meta-analysis of 21,178 patients who underwent
either EVAR or OS for elective AAA repair, EVAR was
associated with shorter intensive care unit/total hospital
stay, fewer cardiac and respiratory complications and lower
mortality rates [20]. However, practise has overtaken theory
and shown another possibility – the use of SG in ruptured
aneurysms. EVAR in emergent setting has a signiﬁcantly
lower risk of 30 day mortality [21–23]. Ruptured aneurysms
need to be treated in the hybrid operating room but under
these conditions SG implantation is advantageous as it is
performed under local anesthesia, more quickly and with
lower invasivity than OS.
The continued development of fenestrated and branched
stent grafts may be questionable, as due to the larger
introducer sheath, an extraperitoneal approach and construc-
tion of the common iliac artery prosthetical conduit will be
necessary for access, thus decreasing the advantage of
its lower invasivity [24]. In addition, a signiﬁcant number
of patients with branched stent grafts suffer from some
endoleak [25]. Abdominal aortic interventions should be
performed only at centers with excellent interdisciplinary
collaboration between vascular surgeons, interventional radi-
ologists and anesthetists.
There is a further risk: between 2000 and 2011 EVAR
procedures in the USA increased from 2358 to 35,028 and, in
the same period, OS procedures decreased from 42,872 to
10,039. University centers now indicate so few open proce-
dures that the number does not cover the demand of the young
physician education program. Inadequately trained physi-
cians have to deal with complicated cases, as the more simple
ones are treated by EVAR [26,27]. In our region there is
the opposite risk: trained endovascular specialists are un-
available outside normal working hours and the outdatedrtion of endovascular procedures ranges from 3 to 11%/year.
of indicated asymptomatic patients and a consequent
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ruptured aneurysms, with a typical mortality rate of 40–50%.
The results of the EVAR I trial were published in 2010. One of
the conclusions was that in the long term no difference was
seen in total mortality or aneurysm-related mortality [28]. This
has resulted in reduced enthusiasm for elective EV treatment
and in a decrease in the total number of EVAR during the last
5 years in our center.
Carotid artery stenting (CAS) has experienced increased
popularity during the last decade. However, the data from
international studies has failed to persuade many experts
that the method is equally effective. Restenosis is more
frequent after carotid stenting than after endarterectomy [29].
There is a 20% higher risk of silent brain infarction after
stenting, although without measurable change in cognitive
functions [30]. Recommendations to give preference to CAS
rather than to open endarterectomy should be accepted with
caution, as they often reﬂect a desire rather than the reality
[31,32].
Specialized centers have adapted to changes in the disci-
pline and adopted endovascular methods in their portfolia.
Occasional voices are still heard predicting that endovascular
procedures will completely replace open vascular surgery,
which as a speciality will decline. The experience in our center,
the Vascular Surgery Department of Na Homolce Hospital,
similarly to many other European centers, conﬁrms that
vascular surgeons are having to take on the more comprehen-
sive role of vascular specialists. This physician will identify
potential patients and be able to investigate them using
sonography, angiography or other methods developed in the
future. The specialist will then choose and apply the appropriate
treatment method alone. The current board education
for vascular specialist should move toward reﬂecting this
approach.
Conﬂict of interest
All authors declare that there is no conﬂict of interest and
there was no outside support funding.
Funding body
Sponsored by Ministry of Health, Czech Republic – conceptual
development of research organization (Na Homolce Hospital,
NNH, 00023884).
Ethical statement
All authors declare that the research published in this
manuscript was done according to ethical standards.
Informed consent
All authors declare the patients signed informed consents
before all the procedures which were retrospectively followed
in this manuscript.r e f e r e n c e s
[1] J. Thompson, History of vascular surgery, in: J.A. Norton,
et al. (Eds.), Surgery, Basic Science and Clinical Evidence,
Springer, New York, 2008.
[2] B. Katzen, J. Chang, Percutaneous transluminal angioplasty
(PTA) with the Grüntzig balloon catheter: technical
problems encountered in the ﬁrst forty patients,
Cardiovascular Radiology 2 (1979) 3–7.
[3] L. Brown, J. Powell, Risk factors for aneurysm rupture in
patients kept under ultrasound surveillance. UK Small
Aneurysm Trial Participants, Annals of Surgery 230 (1999)
289–296.
[4] M. De Bakey, D. Cooley, Surgical treatment of aneurysm of
abdominal aorta by resection and restoration of continuity
with homograft, Surgery, Gynecology and Obstetrics
97 (1953) 257–266.
[5] A. Karthikesalingam, R. Cobb, A. Khoury, et al., The
morphological applicability of a novel endovascular
aneurysm sealing (EVAS) system (Nellix) in patients with
abdominal aortic aneurysms, European Journal of Vascular
and Endovascular Surgery 46 (2013) 440–445.
[6] T. Brott, J. Halperin, S. Abbara, et al., 2011ASA/ACCF/AHA/
AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/
SVS/guideline on the management of patients with
extracranial carotid and vertebral artery disease: executive
summary and practice guidelines, Catheterization and
Cardiovascular Interventions 81 (2013) E76–E123.
[7] H. Marcus, A. MacKinnon, Asymptomatic embolization
detected by Doppler ultrasound predicts stroke risk in
symptomatic carotid artery stenosis, Stroke 36 (2005) 971–975.
[8] J. Molloy, H. Marcus, Asymptomatic embolization predicts
stroke and TIA risk in patients with carotid artery stenosis,
Stroke 30 (1999) 1440–1443.
[9] H. Arazi, F. Capparelli, B. Linetzky, et al., Carotid
endarterectomy in asymptomatic carotid stenosis: a
decision analysis, Clinical Neurology and Neurosurgery
110 (2008) 472–479.
[10] K. Rerkasem, P. Rothwell, Systematic review of randomized
controlled trials of patch angioplasty versus primary closure
and different types of patch materials during carotid
endarterectomy, Asian Journal of Surgery 34 (2011) 32–40.
[11] P. Cao, P. de Rango, S. Zannetti, et al., Eversion versus
conventional carotid endarterectomy for preventing stroke,
Cochrane Database of Systematic Reviews (1) (2001)
CD001921.
[12] P. Šedivý, P. Šebesta, K. Weiss, Operace karotid na prahu
nového století – je čas zpřísnit kritéria výsledků! (Abstract),
Cor et Vasa 52 (2010) 674.
[13] C. Rockman, S. Loh, Carotid endarterectomy: still the
standard of care for carotid bifurcation disease, Seminars in
Vascular Surgery 24 (2011) 10–20.
[14] International Carotid Stenting Study investigators,
J. Ederle, J. Dobson, R. Featherstone, et al., Carotid artery
stenting compared with endarterectomy in patients with
symptomatic carotid stenosis (International Carotid
Stenting Study): an interim analysis of a randomized
controlled trial, Lancet 376 (9736) (2010) 90.
[15] SPACE Collaborative Group, P. Ringleb, J. Allenberg,
H. Brückmann, et al., 30 day results from the SPACE trial of
stent-protected angioplasty versus carotid endarterectomy
in symptomatic patients: a randomized non-inferiority
trial, Lancet 368 (2006) 1239–1247.
[16] J. Mas, G. Chatellier, B. Beyssen, et al., EVA-3S Investigators,
Endarterectomy versus stenting in patients with
symptomatic severe carotid stenosis, New England Journal
of Medicine 355 (2006) 1660–1671.
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 1 0 1 – e 1 0 7 e107[17] T. Brott, R. Hobson 2nd, G. Howard, et al., CREST
Investigators, Stenting versus endarterectomy for
treatment of carotid artery stenosis, New England Journal
of Medicine 363 (2010) 11–23.
[18] D. Lindström, M. Jonsson, J. Formgren, et al., Outcome after
7 years of carotid artery stenting and endarterectomy in
Sweden – single center and national results, European Journal
of Vascular and Endovascular Surgery 43 (2012) 499–503.
[19] K. Wasser, S. Schnaudigel, J. Wohlfahrt, et al., Impact and
predictors of carotid artery in-stent restenosis, Journal of
Neurology 259 (2012) 1896–1902.
[20] R. Lovegrove, M. Javid, T. Magee, R. Galland, A meta-
analysis of 21178 patients undergoing open or endovascular
repair of abdominal aortic aneurysm, British Journal of
Surgery 95 (2008) 677–684.
[21] P. Speicher, A. Barbas, L. Mureebe, Open versus endovascular
repair of ruptured abdominal aortic aneurysms, Annals of
Vascular Surgery 25 (5) (2014) 1249–1257.
[22] J. Ten Bosch, P. Cuypers, M. van Sambeek, J. Teijink, Current
insights in endovascular repair in ruptured abdominal
aortic aneurysms, Eurointervention 7 (2011) 852–858.
[23] D. Thomas, E. Hulten, S. Ellis, et al., Open versus
endovascular repair of abdominal aortic aneurysm in the
elective and emergent setting in a pooled population of
37 781 patients: a systematic review and meta-analysis,
ISRN Cardiology (2014), http://dx.doi.org/10.155/2014/
149243.
[24] J. Lee, G. Lee, V. Chandra, R. Dalman, Comparison of
fenestrated endografts and the snorkel/chimney technique,
Journal of Vascular Surgery 60 (2014) 849–857.[25] R. Blair, A. Collins, D. Harkin, Complex EVAR for abdominal
aorto-iliac aneurysms (AAIA) is associated with high rate of
endoleak and less aortic sac shrinkage compared to
conventional EVAR for AAA, Irish Journal of Medical
Science (2014) (ahead of print).
[26] A. Dua, G. Upchurch, J. Lee, et al., Predicted shortfall in open
aneurysm experience for vascular surgery trainees, Journal
of Vascular Surgery 60 (2014) 945–949.
[27] A. Dua, S. Kuy, C. Lee, et al., Epidemiology of aortic
aneurysm repair in the United States from 2000 to 2010,
Journal of Vascular Surgery 59 (2014) 1512–1517.
[28] UK EVAR Trial Investigators, R. Greenhalg, L. Brown,
J. Powell, et al., Endovascular versus open repair of
abdominal aortic aneurysm, New England Journal of
Medicine 362 (2010) 1863–1871.
[29] C. Arquizan, L. Trinquart, P. Touboul, et al., EVA-3S
Investigators, Restenosis is more frequent after carotid
stenting than after endarterectomy: the EVA-3S study,
Stroke 42 (2011) 1015–1020.
[30] M. Kuliha, M. Roubec, V. Procházka, et al., Randomized
clinical trial comparing neurological outcomes after carotid
endarterectomy or stenting, British Journal of Surgery
102 (2015) 194–201.
[31] K. Paraskevas, F. Veith, The indications of carotid artery
stenting in symptomatic patients may need to be
reconsidered, Annals of Vascular Surgery 29 (2015) 154–159.
[32] R. McDonald, J. McDonald, T. Therneau, et al., Comparative
effectiveness of carotid revascularization therapies:
evidence from a National Hospital Discharge Database,
Stroke 45 (2014) 3311–3319.
